bioRxivMicrobiologyPreprint
Bioinformatic analyses of plasmid resistome changes in pOXA-48
Abstract
Infections caused by carbapenem resistant Enterobacteriales (CPE) represent a significant threat in clinical settings. blaOXA-48 is one of the most frequent carbapenemase genes among Enterobacteriales. The blaOXA-48 is typically encoded on the prototypical IncL conjugative pOXA-48 plasmid. The pOXA-48 plasmid encodes only the blaOXA-48 resistance gene. However, aminoglycoside and extended spectrum {beta}-lactamase (ESBL) resistance genes have also been detected on the same pOXA-48 plasmid backbone. These pOXA-48 plasmids encoding additional antimicrobial resistance (AMR) genes have been associated with both poor patient outcome and increased minimal inhibitory concentrations (MICs) to antibiotics including broad-spectrum cephalosporins. The blaOXA-48 gene was sourced from the pOXA-48 reference plasmid and set as a query using the BLASTn tool. Non-duplicate blaOXA-48 containing plasmids were downloaded, incompatibility typed and annotated for resistance genes using ResFinder 4.0. Bioinformatic analyses identified three distinct variants of the pOXA-48 plasmid encoding 4, 5, and 6 antimicrobial resistance genes. All plasmids encoded the ESBL blaCTX-M-14b, blaOXA-48 and either 2, 3 or 4 aminoglycoside resistance genes, in addition to conjugative transfer machinery. Plasmid variants 1 and 3 encoded aminoglycoside genes bracketed between IS26 and ISEc63 insertion elements, forming a potential transposon. The potential transposon structure had resemblance to the Tn5393 transposon (accession: M96392), including both aph(3)-Ib, aph(6)-Id genes, and a Tn3 resolvase. The IS element ISEcp1 lies upstream of blaCTX-M-14b. All three plasmid variants appear related. Notably, all pOXA-48 plasmid variants were identified in multiple countries. In particular, variant 1 including 6 AMR genes was detected in 7 unique countries. Plasmids encoding additional AMR genes were associated with clinical/surveillance samples suggesting antibiotic pressure in clinical settings may promote changes in the resistome of pOXA-48. Acquisition of pOXA-48 resistant plasmids carrying additional AMR genes beyond blaOXA-48 can change the resistome of susceptible isolates in a single-step, rendering previously susceptible strains refractory to almost all available treatment options.
- organism: human
- assay: whole-genome sequencing
- research focus: clustering
- approach: biophysical modeling
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- blaOXA-48-like genome architecture among carbapenemase-producing Escherichia coli and Klebsiella pneumoniae in the Netherlands
A. P. A. Hendrickx, F. Landman, … L. M. Schouls·bioRxiv·Dec 18, 2020
- OXA-1207, a new OXA-48-type carbapenem-hydrolysing class D beta lactamase from Escherichia coli
Julian Sommer, Marie Welter, … Stephan Göttig·bioRxiv·Jul 31, 2025
- Dissemination routes of the carbapenem resistance plasmid pOXA-48 in a hospital setting
R. Leon-Sampedro, J. DelaFuente, … A. San Millan·bioRxiv·Apr 20, 2020
- Hospital outbreak of carbapenem-resistant Enterobacteriales associated with an OXA-48 plasmid carried mostly by Escherichia coli ST399
A. Ledda, M. Cummins, … X. Didelot·bioRxiv·Jun 15, 2020
- Long read sequencing provides an insight into plasmids found among carbapenemase producing Enterobacterales from hospitals in the United Kingdom during 2021 to 2023
Jane F. Turton, Jack A Turton·bioRxiv·Mar 19, 2024
- Antimicrobial resistance level and conjugation permissiveness shape plasmid distribution in clinical enterobacteria
A. Alonso-del Valle, L. Toribio-Celestino, … A. San Millan·bioRxiv·Apr 3, 2023